ロード中...
Once-monthly risedronate for postmenopausal osteoporosis
Bisphosphonates are the mainstay of treatment for postmenopausal women with osteoporosis. Despite numerous clinical trials documenting efficacy, tolerability, and safety of bisphosphonate therapy, long-term persistence and adherence to these agents remains low. This has serious consequences for pati...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2971711/ https://ncbi.nlm.nih.gov/pubmed/21072270 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|